Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Farmers Insurance
Covington
Argus Health
Express Scripts
McKinsey
Baxter
Accenture

Generated: July 22, 2018

DrugPatentWatch Database Preview

Carbamazepine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for carbamazepine and what is the scope of carbamazepine freedom to operate?

Carbamazepine
is the generic ingredient in eight branded drugs marketed by Apotex Inc, Mylan Ireland Ltd, Taro, Teva Pharms, Shire, Validus Pharms, Lundbeck Pharms Llc, Wockhardt Bio Ag, Novartis, Taro Pharm, Jubilant Cadista, Taro Pharm Inds, Torrent Pharms, Teva, Actavis Elizabeth, Inwood Labs, Pliva, Usl Pharma, and Warner Chilcott, and is included in twenty-nine NDAs. There are seven patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Carbamazepine has sixty patent family members in twenty countries.

There are twenty-seven drug master file entries for carbamazepine. Forty-two suppliers are listed for this compound. There is one tentative approval for this compound.
Medical Subject Heading (MeSH) Categories for carbamazepine
Synonyms for carbamazepine
11-benzo[b][1]benzazepinecarboxamide
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,9,12,14-HEPTAENE-2-CARBOXAMIDE
298-46-4
33CM23913M
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyldibenzo(b,f)azepine
5-Carbomoyl-5H-dibenzo(b,f)azepine
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz[ b, f]azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5-carboxamine
5H-Dibenzo[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide #
5H-dibenzo[b,f]azepine-5-carboximidic acid
85756-57-6 (di-hydrate)
A820074
AB00051931_19
AB00051931_20
AB00051931-17
AB00051931-18
AB0070254
AB1009530
AC-9538
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
ACT02606
AJ-08227
AJ-08230
AK116064
AKOS003235644
AKOS025397243
Amizepin
Amizepine
AN-6325
AOB5783
Apo-Carbamazepine
Atretol
Azapentacene; Sodium 5,12-dihydroazapentacene disulfonate; 5,12-Dihydroquinoxalino[2,3-b]phenazine sulfonate sodium salt
BBL005372
BC200975
BDBM50003659
benzo[b][1]benzazepine-11-carboxamide
BG0497
BIDD:GT0479
BIM-0050280.0001
Bio-0751
Bipotrol
Biston
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
C 4024
C-13993
C06868
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
Carbamazepine (Carbatrol)
Carbamazepine (iv, epilepsy)
Carbamazepine (iv, epilepsy), Lundbeck
Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals
Carbamazepine (JP17/USP/INN)
carbamazepine (Tegretol)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepine [USAN:USP:INN:BAN:JAN]
Carbamazepine 1.0 mg/ml in Methanol
Carbamazepine Anhydrous
carbamazepine hydrate
Carbamazepine Hydrochloride
Carbamazepine Phosphate
Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
carbamazepine sulfate
carbamazepine tartrate
Carbamazepine, analytical standard
Carbamazepine, British Pharmacopoeia (BP) Reference Standard
Carbamazepine, European Pharmacopoeia (EP) Reference Standard
Carbamazepine, meets USP testing specifications
Carbamazepine, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Carbamazepine, powder
CARBAMAZEPINE, U.S.P.
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
Carnexiv
CAS-298-46-4
CBChromo1_000350
CC-25382
CC-25383
CCG-38931
CDS1_002710
CHEBI:3387
CHEMBL108
ChemDiv1_018966
CPD001227191
CS-2225
D00252
D04MSM
DB00564
dibenz[b,f]azepine-5-carboxamide
dibenzo[b,f]azepine-5-carboxamide
Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine)
DivK1c_000388
DivK1c_003750
DR000542
DSSTox_CID_2731
DSSTox_GSID_22731
DSSTox_RID_76704
DTXSID4022731
EINECS 206-062-7
EN300-21678
Epitol
Epitope ID:174842
Equetro
Equetro (TN)
EU-0100292
F0348-2551
FFGPTBGBLSHEPO-UHFFFAOYSA-N
Finlepsin
FT-0602927
FT-0696814
G 32883
G-32883
Geigy 32883
GP8250
GTPL5339
H2605
H495
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS2095K05
HMS2233G16
HMS3039K09
HMS3259B21
HMS3260L06
HMS3372J13
HMS3657G03
HMS501D10
HMS640O02
HSDB 3019
HY-B0246
I06-0863
IDI1_000388
IMED104589831
Iminostilbene-N-carboxamide
Karbamazepin
KB-246109
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
KS-00000KI8
KS-5146
Lexin
Lopac-C-4024
Lopac0_000292
LP00292
LS-60362
MCULE-9121567287
MFCD00005073
MLS000069652
MLS001055475
MLS001074172
MLS002548877
MolPort-000-710-574
MolPort-023-220-275
NC00679
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-04
NCGC00015234-05
NCGC00015234-06
NCGC00015234-07
NCGC00015234-08
NCGC00015234-09
NCGC00015234-10
NCGC00015234-11
NCGC00015234-12
NCGC00015234-13
NCGC00015234-14
NCGC00015234-15
NCGC00015234-16
NCGC00015234-19
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NCGC00253982-01
NCGC00259822-01
NCGC00260977-01
Neurotol
Neurotop retard
NINDS_000388
Novo-Carbamaz
NSC 169864
NSC-169864
NSC-755920
NSC169864
NSC755920
Nu-Carbamazepine
Opera_ID_72
Oprea1_790775
Pharmakon1600-01500159
PL053430
Prestwick_104
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Q-200792
s1693
SAM002264603
SBI-0050280.P004
SC-16243
SCHEMBL21639
Sirtal
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
Spectrum_000096
SPECTRUM1500159
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
SR-01000000229
SR-01000000229-2
ST075773
ST2418853
Stazepin
Stazepine
STK177357
STL453548
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Tox21_110104
Tox21_110104_1
Tox21_202273
Tox21_300195
Tox21_500292
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
Z2199879032
ZB000594
ZINC4785
Tentative approvals for CARBAMAZEPINE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial100MGCAPSULE, EXTENDED RELEASE; ORAL
➤ Try a Free Trial➤ Try a Free Trial300MGCAPSULE, EXTENDED RELEASE; ORAL
➤ Try a Free Trial➤ Try a Free Trial200MGCAPSULE, EXTENDED RELEASE; ORAL

US Patents and Regulatory Information for carbamazepine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro CARBAMAZEPINE carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 201106-002 Jun 21, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pliva CARBAMAZEPINE carbamazepine TABLET;ORAL 071479-001 Jul 24, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis TEGRETOL-XR carbamazepine TABLET, EXTENDED RELEASE;ORAL 020234-003 Mar 25, 1996 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for carbamazepine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms EQUETRO carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 021710-002 Dec 10, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis TEGRETOL-XR carbamazepine TABLET, EXTENDED RELEASE;ORAL 020234-002 Mar 25, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Shire CARBATROL carbamazepine CAPSULE, EXTENDED RELEASE;ORAL 020712-001 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis TEGRETOL carbamazepine TABLET;ORAL 016608-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for carbamazepine

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,200,088 Sulfoalkyl ether cyclodextrin compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Queensland Health
Johnson and Johnson
Merck
Cerilliant
UBS
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.